The worldwide pandemic of asbestos-related diseases
- PMID: 23297667
- DOI: 10.1146/annurev-publhealth-031811-124704
The worldwide pandemic of asbestos-related diseases
Abstract
Asbestos-related diseases are still a major public health problem. The World Health Organization (WHO) has estimated that 107,000 people worldwide die each year from mesothelioma, lung cancer, and asbestosis. We review what is known about asbestos use, production, and exposure and asbestos-related diseases in the world today, and we offer predictions for the future. Although worldwide consumption of asbestos has decreased, consumption is increasing in many developing countries. The limited data available suggest that exposures may also be high in developing countries. Mesothelioma is still increasing in most European countries and in Japan but has peaked in the United States and Sweden. Although the epidemic of asbestos-related disease has plateaued or is expected to plateau in most of the developed world, little is known about the epidemic in developing countries. It is obvious that increased asbestos use by these countries will result in an increase in asbestos-related diseases in the future.
Similar articles
-
Projections of asbestos-related disease 1980-2009.J Occup Med. 1983 May;25(5):409-25. J Occup Med. 1983. PMID: 6854431
-
An updated review on asbestos and related diseases in China.Int J Occup Environ Health. 2012 Jul-Sep;18(3):247-53. doi: 10.1179/1077352512Z.00000000021. Int J Occup Environ Health. 2012. PMID: 23026008 Review.
-
The use of asbestos in Japan and China and malignancy related findings.Med Lav. 1995 Sep-Oct;86(5):457-60. Med Lav. 1995. PMID: 8684296
-
National epidemiologic surveillance systems of asbestos-related disease and the exposed workers register.Med Lav. 2006 May-Jun;97(3):482-7. Med Lav. 2006. PMID: 17009684
-
Descriptive epidemiology of malignant mesothelioma.Med Lav. 2005 Jul-Aug;96(4):287-303. Med Lav. 2005. PMID: 16457426 Review.
Cited by
-
Asbestos Exposure and Malignant Pleural Mesothelioma: A Systematic Review of Literature.Port J Public Health. 2023 Jan 10;40(3):188-202. doi: 10.1159/000527971. eCollection 2023 Feb. Port J Public Health. 2023. PMID: 39469260 Free PMC article. Review.
-
Burden of malignant mesothelioma in China during 1990-2019 and the projections through 2029.J Natl Cancer Cent. 2024 May 11;4(3):214-222. doi: 10.1016/j.jncc.2024.05.003. eCollection 2024 Sep. J Natl Cancer Cent. 2024. PMID: 39281715 Free PMC article.
-
The Pleural Mesothelioma Cases and Mortality in Portugal in 2014-2020: A Descriptive Study.Healthcare (Basel). 2024 May 28;12(11):1103. doi: 10.3390/healthcare12111103. Healthcare (Basel). 2024. PMID: 38891178 Free PMC article.
-
Mesothelioma diagnosis-still a challenge.J Bras Pneumol. 2024 May 27;50(2):e20240118. doi: 10.36416/1806-3756/e20240118. J Bras Pneumol. 2024. PMID: 38808836 Free PMC article. No abstract available.
-
Effects of different amosite preparations on macrophages, lung damages, and autoimmunity.J Mol Med (Berl). 2024 Feb;102(2):197-211. doi: 10.1007/s00109-023-02401-9. Epub 2023 Nov 28. J Mol Med (Berl). 2024. PMID: 38015242
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
